X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (19) 19
humans (18) 18
cardiovascular (17) 17
cardiac & cardiovascular systems (16) 16
abridged index medicus (15) 15
cardiology (9) 9
female (9) 9
heart attacks (9) 9
internal medicine (9) 9
male (8) 8
mortality (8) 8
medical colleges (7) 7
middle aged (7) 7
acute coronary syndromes (6) 6
aged (6) 6
platelet aggregation inhibitors - therapeutic use (6) 6
treatment outcome (6) 6
aspirin (5) 5
clopidogrel (5) 5
coronary vessels (5) 5
drug therapy (5) 5
drug therapy, combination (5) 5
patients (5) 5
studies (5) 5
thrombosis (5) 5
antiplatelet therapy (4) 4
association (4) 4
blood platelets (4) 4
cardiac patients (4) 4
cardiology and cardiovascular medicine (4) 4
cardiovascular disease (4) 4
continuing medical education (4) 4
coronary heart disease (4) 4
drug dosages (4) 4
medical care (4) 4
medicine & public health (4) 4
physicians (4) 4
practice guidelines as topic (4) 4
risk factors (4) 4
adult (3) 3
aspirin - administration & dosage (3) 3
biography (3) 3
body mass index (3) 3
cardiovascular diseases - prevention & control (3) 3
care and treatment (3) 3
clinical trials (3) 3
congresses as topic (3) 3
cross-over studies (3) 3
diabetes (3) 3
dose-response relationship, drug (3) 3
double-blind method (3) 3
medical research (3) 3
medicine, experimental (3) 3
myocardial infarction (3) 3
outcomes (3) 3
platelet aggregation inhibitors - administration & dosage (3) 3
platelet aggregation inhibitors - adverse effects (3) 3
platelets (3) 3
prevention (3) 3
quality management (3) 3
research institutes (3) 3
risk (3) 3
stroke (3) 3
ticlopidine - analogs & derivatives (3) 3
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (2) 2
aged patients (2) 2
angina pectoris (2) 2
anticoagulants (2) 2
antithrombotic therapy (2) 2
area under curve (2) 2
article (2) 2
aspirin - adverse effects (2) 2
atherosclerosis (2) 2
atrial fibrillation (2) 2
blood coagulation - drug effects (2) 2
cardiac arrhythmia (2) 2
chronic disease (2) 2
chronic stable angina (2) 2
colleges & universities (2) 2
confidence intervals (2) 2
coronary disease - therapy (2) 2
cytochrome p-450 (2) 2
decision making (2) 2
demographics (2) 2
dictionaries (2) 2
disclosure (2) 2
disease (2) 2
drug interactions (2) 2
early revascularization (2) 2
electrocardiography (2) 2
gastroenterology and hepatology (2) 2
health information technology (2) 2
health policy (2) 2
heart diseases (2) 2
heart-failure (2) 2
hematology (2) 2
hemorrhage - chemically induced (2) 2
hospitals (2) 2
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2) 2
incidence (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Closed Orders (4) 4
Gerstein Science - Stacks (2) 2
Music - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Music - Library use only (1) 1
Robarts - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 61, Issue 8, pp. 872 - 879
Objectives This study sought to determine whether known genetic, drug, dietary, compliance, and lifestyle factors affecting clopidogrel absorption and... 
Cardiovascular | Internal Medicine | pharmacokinetics | risk factors | receptors | drugs | platelets | CARDIAC & CARDIOVASCULAR SYSTEMS | EFFICACY | GENOTYPE | REACTIVITY | TRIAL | CIGARETTE-SMOKING | PARAOXONASE-1 | RESISTANCE | PRASUGREL | ABSORPTION | ASSOCIATION | Area Under Curve | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Drug Monitoring - methods | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - blood | Ticlopidine - administration & dosage | Adult | Female | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Drug Therapy, Combination | Platelet Aggregation - genetics | Cardiovascular Diseases - etiology | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacokinetics | Platelet Function Tests - methods | Aryldialkylphosphatase - genetics | Ticlopidine - analogs & derivatives | Polymorphism, Genetic | Cross-Over Studies | Smoking - metabolism | Confounding Factors (Epidemiology) | Proton Pump Inhibitors - pharmacokinetics | Blood Coagulation - drug effects | ATP-Binding Cassette, Sub-Family B, Member 1 - genetics | Cytochrome P-450 CYP2C19 | ATP Binding Cassette Transporter, Sub-Family B | Cardiovascular Diseases - psychology | Patient Compliance | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Phosphates | Drugs | Prescribing | Medical colleges | Continuing medical education | Metabolites | Vasodilators | Cytochrome P-450 | Physiological aspects | Proton pump inhibitors | Genetic aspects | Patient compliance | Research institutes | Studies | Cytochrome | Body mass index | Nutrition research | Genotype & phenotype | Demographics | Drug therapy | Acute coronary syndromes | Drug dosages | Index Medicus | Abridged Index Medicus
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2012, Volume 59, Issue 14, pp. 1304 - 1311
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 6, pp. 603 - 612
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 2, pp. 176 - 185
Abstract Background Cangrelor, an intravenous, reversible P2Y12 antagonist, is approved for use in patients undergoing percutaneous coronary intervention... 
Cardiovascular | Internal Medicine | coronary artery disease | bleeding | antiplatelet therapy | outcomes | CARDIAC & CARDIOVASCULAR SYSTEMS | PRIMARY PCI | BIVALIRUDIN | IMPAIRED BIOAVAILABILITY | CHAMPION PHOENIX | CLOPIDOGREL | PLATELET INHIBITION | BLOOD-TRANSFUSION | ELEVATION MYOCARDIAL-INFARCTION | INSIGHTS | Prospective Studies | Ticlopidine - therapeutic use | Humans | Middle Aged | Male | Aspirin - adverse effects | Ticlopidine - adverse effects | Female | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Angioplasty, Balloon, Coronary - methods | Myocardial Ischemia - prevention & control | Treatment Outcome | Adenosine Monophosphate - therapeutic use | Ticlopidine - analogs & derivatives | Adenosine Monophosphate - adverse effects | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Adenosine Monophosphate - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Infusions, Intravenous | Cohort Studies | Transluminal angioplasty | Continuing medical education | Cardiac patients | Medical care | Research institutes | Cardiology | Quality management | Heart attacks | Mortality | Thrombosis | Patients | Studies | Consortia | Ischemia | Coronary vessels | Bailouts | Intubation | Acute coronary syndromes | Stents | Drug dosages | Veins & arteries | Index Medicus | Abridged Index Medicus
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 6, pp. 616 - 627
Abstract Background Antithrombotic therapy for acute myocardial infarction (MI) with atrial fibrillation (AF) among higher risk older patients treated with... 
Cardiovascular | Internal Medicine | atrial fibrillation | percutaneous coronary intervention | antithrombotic therapy | myocardial infarction | atrial fibrillation | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK | CLINICAL CLASSIFICATION SCHEMES | NATIONAL REGISTRY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | ANTICOAGULATION | ASSOCIATION | WARFARIN USE | Myocardial Infarction - epidemiology | Purinergic P2Y Receptor Antagonists - administration & dosage | Anticoagulants - administration & dosage | Humans | Stroke - diagnosis | Warfarin - adverse effects | Male | Warfarin - administration & dosage | Aspirin - administration & dosage | Myocardial Infarction - therapy | Purinergic P2Y Receptor Antagonists - adverse effects | Stroke - chemically induced | Aspirin - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Aged, 80 and over | Female | Registries | Stroke - epidemiology | Atrial Fibrillation - diagnosis | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Myocardial Infarction - diagnosis | Percutaneous Coronary Intervention - trends | Hemorrhage - epidemiology | Atrial Fibrillation - therapy | Treatment Outcome | Anticoagulants - adverse effects | Hemorrhage - diagnosis | Atrial Fibrillation - epidemiology | Aged | Hemorrhage - chemically induced | Transluminal angioplasty | Sects | Medical colleges | Care and treatment | Continuing medical education | Patient outcomes | Atrial fibrillation | Cardiac patients | Aged patients | Cardiac arrhythmia | Anticoagulants | Stroke | Hospitalization | Heart attacks | Cardiology | Index Medicus | Abridged Index Medicus
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 23, pp. 2879 - 2879
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 119, Issue 10, pp. 1548 - 1554
Journal Article
by Brilakis, Emmanouil S and Edson, Robert and Bhatt, Deepak L and Goldman, Steven and Holmes, David R and Rao, Sunil V and Rao, Sunil and Shunk, Kendrick and Rangan, Bavana V and Mavromatis, Kreton and Ramanathan, Kodangudi and Bavry, Anthony A and Bavry, Anthony and Garcia, Santiago and Latif, Faisal and Armstrong, Ehrin and Jneid, Hani and Conner, Todd A and Wagner, Todd and Karacsonyi, Judit and Uyeda, Lauren and Ventura, Beverly and Alsleben, Aaron and Lu, Ying and Lu, David and Shih, Mei-Chiung and Banerjee, Subhash and Ahmed, Zubair and Ahmed, Bina and Ratliff, D Michelle and Ricciardi, Mark and Sheldon, Mark and Icenogle, Milton and Snider, Richard and Ardati, Amer and Nallamothu, Brahmajee and Duvernoy, Claire and Menees, Daniel S and Gurm, Hitinder and Thomas, Michael P and Grossman, Paul and Owen, Kristine and Topaz, On and Kumar, Gautam and Kumar, Arun and Block, Peter and Zidar, David A and Bezerra, Hiram and Goldberg, Jonathan and Ortiz, Jose and Jozic, Joseph and Osman, Mohammed and Rosenthal, Noah and Parikh, Sahil A and Lassar, Tom A and Chan, Albert and Aggarwal, Kul and Cyrus, Tillmann and Grodin, Jerrold and Hattler, Brack and Casserly, Ivan and Messenger, John and Kim, Michael and Rogers, R Kevin and Waldo, Stephen and Tsai, Thomas and Morris, Kenneth and Krucoff, Mitchell and Povsic, Thomas J and Jones, William S and Choi, Calvin and Park, Ki and Liu, MD, Jayson and Kar, Biswajit and Paniagua, David and Breall, Jeffrey and Bolad, Islam and Mukerji, Rita and Subbarao, Roopa and Abdel-Latif, Ahmed and Booth, David C and Ziada, Khaled M and Rajan, Lawrence and Hakeem, Abdul and Uretsky, Barry F and Agrawal, Mayank and Sachdeva, Rajesh and McGee, Jesse and Shah, Rahman and Sharma, Alok and McFalls, Edward and Siddiqui, Rizwan and Adabag, Selcuk and Bertog, Stefan and Irimpen, Anand and Baldwin, Drew and Abi Rafeh, Nidal and Mogabgab, Owen and Delafontaine, Patrice and Lorin, Jeffrey and ... and DIVA Trial Investigators
The Lancet, ISSN 0140-6736, 05/2018, Volume 391, Issue 10134, pp. 1997 - 2007
Journal Article
by Bosch, Jackie, MSc, PhD and Eikelboom, John W., MBBS, MSc and Connolly, Stuart J., MD and Cook Bruns, Nancy, MD and Lanius, Vivian, PhD and Yuan, Fei, MMath and Misselwitz, Frank, MD, PhD and Chen, Edmond, MD and Diaz, Rafael, MD and Alings, Marco, MD, PhD and Lonn, Eva M., MD, MSc and Widimsky, Petr, MD, DSc and Hori, Masatsugu, MD, PhD and Avezum, Alvaro, MD, PhD and Piegas, Leopoldo S., MD and Bhatt, Deepak L., MD, MPH and Branch, Kelley R.H., MD, MSc and Probstfield, Jeffrey L., MD and Liang, Yan, MD and Liu, Lisheng, MD and Zhu, Jun, MD and Maggioni, Aldo P., MD and Lopez-Jaramillo, Patricio, MD, PhD and O’Donnell, Martin, MB, PhD and Fox, Keith A.A., BSc, MBChB and Kakkar, Ajay, MBBS, PhD, BSc, MA and Parkhomenko, Alexander N., MD, PhD and Ertl, Georg, MD and Störk, Stefan, MD, PhD and Keltai, Katalin, MD and Keltai, Matyas, MD and Ryden, Lars, MD and Dagenais, Gilles R., MD and Pogosova, Nana, MD, PhD and Dans, Antonio L., MD, MSc and Lanas, Fernando, PhD and Commerford, Patrick J., MBChB and Torp-Pedersen, Christian, MD and Guzik, Tomasz J., MD, PhD, MSc and Verhamme, Peter B., MD and Vinereanu, Dragos, MD, PhD and Kim, Jae-Hyung, MD, PhD and Ha, Jong-Won, MD, PhD and Tonkin, Andrew M., MD, MBBS and Varigos, John D., BSc (Hon) and Lewis, Basil S., MD and Felix, Camilo, MD, MSc and Yusoff, Khalid, MBBS and Steg, Philippe Gabriel, MD and Aboyans, Victor, MD, PhD and Metsarinne, Kaj P., MD, PhD and Anand, Sonia S., MD, PhD and Hart, Robert G., MD and Lamy, Andre, MD, MHSc and Moayyedi, Paul, BSc, MBChB, PhD and Sharma, Mukul, MD, MSc and Yusuf, Salim, MBBS,-DPhil
Canadian Journal of Cardiology, ISSN 0828-282X, 2017, Volume 33, Issue 8, pp. 1027 - 1035
Journal Article
American Heart Journal, ISSN 0002-8703, 2011, Volume 161, Issue 5, pp. 972 - 978
Journal Article